本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

1.13
+0.08508.17%
盘后1.130.00000.00%18:13 EDT
成交量:5.75万
成交额:6.22万
市值:1,445.97万
市盈率:-1.04
高:1.13
开:1.07
低:1.05
收:1.04
数据加载中...
2019/12/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/24

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/18

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/10/18

SEC问询函

[Cover]Correspondence
2019/10/17

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/17

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/10/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]